100% Quality Guarantee
PhD-Level Technical Support
Cirevetmab Antibody - SDS-PAGE
Key Features

Cirevetmab Antibody (GXBS01352)

SKU GXBS01352
Product Type Research Grade Biosimilar
Antibody Type Monoclonal
Host Species Canine
Reactivity Canine
Applications ELISA, FCM, Functional assay, Research in vivo
Isotype IgG2, kappa
$677 - $2,208

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Cirevetmab Antibody

Cirevetmab Antibody is a research-grade biosimilar monoclonal antibody targeting TGFB1/TGF-beta-1. It is a caninized IgG2, kappa antibody. Reactivity: Canine. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.

Transforming growth factor beta-1 proprotein (TGFB1) is a ~44 kDa protein. Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose